Are randomized clinical trials the only truth? Not always

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 3, 2006, Pages 503-504

  Aledort, L ^a   Ljung, R ^b   Blanchette, Victor ^c   Feldman, Brian ^d   Gringeri, Alessandro ^d   Manco Johnson, Marilyn ^d   Petrini, Pia ^d   Rivard, Georges ^d   Schramm, Wolfgang ^d   van den Berg, Marijke ^d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 9 CONCENTRATE;

ABSENTEEISM; ACADEMIC ACHIEVEMENT; ARTICLE; CLINICAL TRIAL; COST CONTROL; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEALTH CARE POLICY; HEMARTHROSIS; HEMOPHILIA A; HEMOPHILIA B; HOSPITALIZATION; HUMAN; INDIVIDUALIZATION; MEDICAL DECISION MAKING; MEDICAL LITERATURE; ORTHOPEDICS; OUTCOMES RESEARCH; PEER REVIEW; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM;

BLOOD COAGULATION FACTORS; EVIDENCE-BASED MEDICINE; HEMARTHROSIS; HEMOPHILIA A; HUMANS; PREMEDICATION; RANDOMIZED CONTROLLED TRIALS;

EID: 33645975171     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.01841.x     Document Type: Article

References (4)

1. Stobart K, Iorio A, Wu JK. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B (Review). Cochrane Database Syst Rev 2005; CD003429.
2. Carcao MD, Aledort L. Prophylactic factor replacement in hemophilia. Blood Rev 2004; 18: 101-13.
3. Smith GCS, Pell JP. Parachute use to prevent death and major trauma related to gravitational challenge: Systematic review of randomised controlled trials. BMJ 2003; 327: 1459-61.
4. Anonymous. International forum. Prophylactic treatment of patients with haemophilia A or haemophilia B. Vox Sang 2005; 88: 62-7.